Ex-FDA official ends testimony in Vioxx trial
ATLANTIC CITY, New Jersey   - An former official from the U.S. Food and Drug Administration on Friday said Merck & Co. Inc.  properly submitted all information on its Vioxx drug to the regulators, ending testimony in the punitive phase of the product liability trial.
      
       
